论文部分内容阅读
报告了10例以尿激酶、2例以重组组织型纤溶酶原激活剂治疗急性心肌梗塞(AMI)的结果.根据临床判定指标,冠脉再通率达91.8%,其中72.7%的患者发生再灌注心律失常.出血并发症2例.病死率16.7%,可能与心肌缺血-再灌注损伤有关.
The results of 10 cases of acute myocardial infarction (AMI) treated with urokinase and 2 cases of recombinant tissue-type plasminogen activator were reported.According to the clinical criteria, the rate of coronary recanalization reached 91.8%, of which 72.7% Reperfusion arrhythmia, bleeding complications in 2. Case fatality rate of 16.7%, may be related to myocardial ischemia-reperfusion injury.